Skip to main content
SpringerLink
Log in

Drug-resistant Spinal Tuberculosis

  • Review Article
  • Published:
Indian Journal of Orthopaedics Aims and scope Submit manuscript

Abstract

Drug-resistant spinal tuberculosis (TB) is an emerging health problem in both developing and developed countries. In this review article, we aim to define management protocols for suspicion, diagnosis, and treatment of such patients. Spinal TB is a deep-seated paucibacillary lesion, and the demonstration of acid-fast bacilli on Ziehl-Neelsen staining is possible only in 10%–30% of cases. Drug resistance is suspected in patients showing the failure of clinicoradiological improvement or appearance of a fresh lesion of osteoarticular TB while on anti tubercular therapy (ATT) for a minimum period of 5 months. The conventional culture of Mycobacterium tuberculosis remains the gold standard for both bacteriological diagnosis and drug sensitivity testing (DST); however, the high turn around time of 2–6 weeks for detection with added 3 weeks for DST is a major limitation. To overcome this problem, rapid culture methods and molecular methods have been introduced. From a public health perspective, reducing the period between diagnosis and treatment initiation has direct benefits for both the patient and the community. For all patients of drug-resistant spinal TB, a complete Drug-O-Gram should be prepared which includes details of all drugs, their doses, and duration. Patients with confirmed multidrug-resistant TB strains should receive a regimen with at least five effective drugs, including pyrazinamide and one injectable. Patients with resistance to additional antitubercular drugs should receive individualized ATT as per their DST results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Li L, Zhang Z, Luo F, Xu J, Cheng P, Wu Z, et al. Management of drug-resistant spinal tuberculosis with a combination of surgery and individualised chemotherapy: a retrospective analysis of thirty-five patients. IntOrthop 2012;36:277–83.

    Google Scholar 

  2. Multidrug and extensively drug-resistant TB (M/XDR-TB): global report on surveillance and response 2010.

  3. Paramasivan CN, Venkataraman P. Drug resistance in tuberculosis in India. Indian J Med Res 2004;120:377–86.

    CAS  PubMed  Google Scholar 

  4. Johnson J, Kagal A, Bharadwaj R. Factors associated with drug resistance in pulmonary tuberculosis. Indian J Chest Dis Allied Sci 2003;45:105–9.

    PubMed  Google Scholar 

  5. Sharma SK, Mohan A. Multidrug-resistant tuberculosis. Indian J Med Res. 2004;120:354–76.

    CAS  PubMed  Google Scholar 

  6. Park MH, Song EY, Park HJ, Kwon SY, Han SK, Shim YS. HLA-DRB1 and DQB1 gene polymorphism is associated with multidrug-resistant tuberculosis in Korean patients. Hum Immunol 2002;63:S33.

    Article  Google Scholar 

  7. Sharma SK, Turaga KK, Balamurugan A, Saha PK, Pandey RM, Jain NK, et al. Clinical and genetic risk factors for the development of multidrug-resistant tuberculosis in non-HIV infected at a tertiary care center in India: a case-control study. Infect Genet Evol 2003;3:183–8.

    Article  Google Scholar 

  8. Maurya AK, Kant S, Nag VL, Kushwaha RA, Dhole TN. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India. J Postgrad Med. 2012;58(3):185–9.

    Article  CAS  Google Scholar 

  9. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender R, Lalloo U, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575–80.

    Article  Google Scholar 

  10. Tuli SM. Tuberculosis of the spine: A historical review. ClinOrthop 2007;460:29–38.

    CAS  Google Scholar 

  11. Tuli SM. Challenge of therapeutically refractory and multidrug resistant tuberculosis in orthopaedic practice. Indian J Orthop 2002;36:211–3.

    Google Scholar 

  12. Prasad R. Management of multidrug resistant tuberculosis: practitioners view point. Indian J Tuberc 2007;54:3–11.

    PubMed  Google Scholar 

  13. Tuli S. Tuberculosis of the skeletal system. 4th edition. Jaypee Brothers; 2004.

  14. Pawar UM, Kundnani V, Agashe V, Nene A, Nene A. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients. Spine 2009;34(22):E806–10.

    Article  Google Scholar 

  15. Mohan K, Rawall S, Pawar UM, Sadani M, Nagad P, Nene A, et al. Drug resistance patterns in 111 cases of drug-resistant tuberculosis spine. Eur Spine J 2013;22:647–52.

    Article  Google Scholar 

  16. Xu LI, Jian-Zhong X, Xue-Mei L, Bao-Feng G. Drug susceptibility testing guided treatment for drug-resistant spinal tuberculosis: a retrospective analysis of 19 patients. Int Surg. 2013; 98(2):175–80. doi: 10.9738/INTSURG-D-12-00004.1.

    Article  Google Scholar 

  17. Jain AK, Dhammi IK, Modi P, Kumar J, Sreenivasan R, Saini NS. Tuberculosis spine: Therapeutically refractory disease. Indian J Orthop 2012;46:171–8.

    Article  Google Scholar 

  18. Kent TK, Kubica GP. Public health mycobacteriology. A guide for the level III laboratory. Atlanta, Center for Disease Control, 1985. Available from http://wwwnc.cdc.gov/eid/content/12/5/pdfs/v12-n5.pdf [Last accessed on 2016 Mar 15].

  19. Lee CN, Heifets LB. Determination of minimal inhibitory concentrations of antituberculosis drugs by radiometric and conventional methods. Am Rev Respir Dis 1987;136:349–52.

    Article  CAS  Google Scholar 

  20. World Health Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug resistant tuberculosis (MDR-TB). World Health Organization, Geneva, Switzerland, 2008.

    Google Scholar 

  21. World Health Organization. Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational ‘how to’ practical considerations. World Health Organization, Geneva, Switzerland, 2011.

    Google Scholar 

  22. Rahman A, Mahfuza Sahrin, Sadia Afrin, Keith Earley, Shahriar Ahmed, S. M. Mazidur Rahman, and SayeraBanuComparison of Xpert MTB/RIF Assay and GenoTypeMTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis. PLoS One 2016;11(4):e0152694.

    Article  Google Scholar 

  23. Barnard M, Albert H, Coetzee G, O’brien R, Bosman ME. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J RespirCrit Care Med 2008;177:787–92.

    Article  Google Scholar 

  24. Held M, Laubscher M, Zar HJ, Dunn RN. GeneXpert polymerase chain reaction for spinal tuberculosis: an accurate and rapid diagnostic test. Bone Joint J 2014;96-B:1366–9.

    Article  CAS  Google Scholar 

  25. Rufai SB, Kumar P, Singh A, Prajapati S, Balooni V, Singh S. Comparison of Xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis. J ClinMicrobiol 2014;52:1846–52.

    CAS  Google Scholar 

  26. Singhal R, Arora J, Lal P, Bhalla M, Myneeedu VP, Behera D. Comparison of line probe assay with liquid culture for rapid detection of multidrug resistance in Mycobacterium tuberculosis. Indian J Med Res. 2012;136(6):1044–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Madhuri K1, Deshpande S1, Dharmashale S1, Bharadwaj R1. Utility of Line Probe Assay for the Early Detection of Multidrug-Resistant Pulmonary Tuberculosis. J Glob Infect Dis. 2015;7(2):60–5. doi: 10.4103/0974-777X.157237.

    Article  CAS  Google Scholar 

  28. Available from: http://apps.who.int/iris/bitstream/10665/44597/1/97892415015 83_eng.pdf [Last accessed on 2017 Apr 23].

  29. Available from: http://www.who.int/tb/areas-of-work/drug-resistant-tb/MDRTBguidelines2016.pdf [Last accessed on 2017 Apr 23].

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology, University College of Medical Sciences, GTB Hospital, New Delhi, India

    Rumpa Saha

  2. Department of Orthopaedics, University College of Medical Sciences, GTB Hospital, New Delhi, India

    Anil K Jain, Karan Raj Jaggi & Himanshu Bhayana

Authors
  1. Anil K Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karan Raj Jaggi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Himanshu Bhayana
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rumpa Saha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anil K Jain.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jain, A.K., Jaggi, K.R., Bhayana, H. et al. Drug-resistant Spinal Tuberculosis. IJOO 52, 100–107 (2018). https://doi.org/10.4103/ortho.IJOrtho_306_17

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ortho.IJOrtho_306_17

Keywords

MeSH terms

Search

Navigation